category	term	number_of_genes	number_of_genes_in_background	ncbiTaxonId	inputGenes	preferredNames	p_value	fdr	description
COMPARTMENTS	GOCC:0005737	30	7871	9606	SLC15A3,OAS3,CMPK2,OASL,IFIH1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,TAP1,CTSS,GBP4,GBP1,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,SAMD9,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14,RNF213	SLC15A3,OAS3,CMPK2,OASL,IFIH1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,TAP1,CTSS,GBP4,GBP1,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,SAMD9,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14,RNF213	1.43e-07	0.00033	Cytoplasm
COMPARTMENTS	GOCC:0097072	3	6	9606	IFIH1,TLR3,DDX58	IFIH1,TLR3,DDX58	4.74e-07	0.00055	Interferon regulatory factor 3 complex
COMPARTMENTS	GOCC:0005829	18	2919	9606	OAS3,OASL,IFIH1,HERC6,DTX3L,MX2,GBP4,GBP1,IFIT1,IFIT3,ISG15,DDX58,SAMD9,LGALS9,MX1,OAS1,PARP14,RNF213	OAS3,OASL,IFIH1,HERC6,DTX3L,MX2,GBP4,GBP1,IFIT1,IFIT3,ISG15,DDX58,SAMD9,LGALS9,MX1,OAS1,PARP14,RNF213	8.21e-07	0.00063	Cytosol
COMPARTMENTS	GOCC:0005622	33	11202	9606	SLC15A3,OAS3,CMPK2,OASL,SP110,SAMHD1,IFIH1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,TAP1,CTSS,GBP4,GBP1,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,SAMD9,RSAD2,LGALS9,MX1,IFITM1,OAS1,HELZ2,PARP14,RNF213	SLC15A3,OAS3,CMPK2,OASL,SP110,SAMHD1,IFIH1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,TAP1,CTSS,GBP4,GBP1,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,SAMD9,RSAD2,LGALS9,MX1,IFITM1,OAS1,HELZ2,PARP14,RNF213	6.5e-06	0.003	Intracellular
COMPARTMENTS	GOCC:0042825	2	3	9606	TAP1,TAP2	TAP1,TAP2	3.27e-05	0.0126	TAP complex
COMPARTMENTS	GOCC:0043231	26	7476	9606	SLC15A3,OAS3,CMPK2,OASL,SP110,SAMHD1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TAP1,CTSS,GBP4,GBP1,IFIT3,IFIT2,TAP2,ISG15,RSAD2,LGALS9,MX1,IFITM1,HELZ2,RNF213	SLC15A3,OAS3,CMPK2,OASL,SP110,SAMHD1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TAP1,CTSS,GBP4,GBP1,IFIT3,IFIT2,TAP2,ISG15,RSAD2,LGALS9,MX1,IFITM1,HELZ2,RNF213	3.69e-05	0.0126	Intracellular membrane-bounded organelle
COMPARTMENTS	GOCC:0098844	2	5	9606	MX2,MX1	MX2,MX1	6.85e-05	0.0198	Postsynaptic endocytic zone membrane
COMPARTMENTS	GOCC:0044327	2	7	9606	MX2,MX1	MX2,MX1	0.00012	0.0301	Dendritic spine head
COMPARTMENTS	GOCC:0043227	27	8685	9606	SLC15A3,OAS3,CMPK2,OASL,SP110,SAMHD1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TAP1,CTSS,GBP4,GBP1,IFIT3,IFIT2,TAP2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,HELZ2,RNF213	SLC15A3,OAS3,CMPK2,OASL,SP110,SAMHD1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TAP1,CTSS,GBP4,GBP1,IFIT3,IFIT2,TAP2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,HELZ2,RNF213	0.00019	0.0412	Membrane-bounded organelle
COMPARTMENTS	GOCC:0043229	28	9242	9606	SLC15A3,OAS3,CMPK2,OASL,SP110,SAMHD1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TAP1,CTSS,GBP4,GBP1,IFIT3,IFIT2,TAP2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,HELZ2,RNF213	SLC15A3,OAS3,CMPK2,OASL,SP110,SAMHD1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TAP1,CTSS,GBP4,GBP1,IFIT3,IFIT2,TAP2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,HELZ2,RNF213	0.00018	0.0412	Intracellular organelle
Process	GO:0051607	20	210	9606	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	6.54e-30	8.41e-26	Defense response to virus
Process	GO:0009615	21	293	9606	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1	4.54e-29	2.92e-25	Response to virus
Process	GO:0060337	14	67	9606	OAS3,OASL,SAMHD1,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,SAMHD1,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	4.57e-25	1.96e-21	Type i interferon signaling pathway
Process	GO:0045087	23	703	9606	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,GBP4,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,GBP4,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14	1.25e-24	2.91e-21	Innate immune response
Process	GO:0098542	24	900	9606	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14	7.92e-24	1.45e-20	Defense response to other organism
Process	GO:0051707	26	1256	9606	OAS3,CMPK2,OASL,SAMHD1,IFIH1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14	OAS3,CMPK2,OASL,SAMHD1,IFIH1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14	1.7e-23	2.73e-20	Response to other organism
Process	GO:0044419	29	1899	9606	OAS3,CMPK2,OASL,SP110,SAMHD1,IFIH1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,TAP1,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14	OAS3,CMPK2,OASL,SP110,SAMHD1,IFIH1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,TAP1,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14	2.14e-23	2.75e-20	Interspecies interaction between organisms
Process	GO:0006955	27	1588	9606	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,TAP1,CTSS,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,TAP1,CTSS,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14	1.98e-22	2.12e-19	Immune response
Process	GO:0006952	25	1296	9606	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,TAP1,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,TAP1,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14	1.22e-21	1.21e-18	Defense response
Process	GO:0002376	28	2481	9606	OAS3,OASL,SAMHD1,IFIH1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,TAP1,CTSS,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14	OAS3,OASL,SAMHD1,IFIH1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,TAP1,CTSS,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14	9.37e-19	8.6e-16	Immune system process
Process	GO:0002252	21	969	9606	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,CTSS,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,CTSS,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	1.3e-18	1.11e-15	Immune effector process
Process	GO:0045071	10	61	9606	OAS3,OASL,ISG20,OAS2,IFIT1,ISG15,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,ISG20,OAS2,IFIT1,ISG15,RSAD2,MX1,IFITM1,OAS1	4.73e-17	3.8e-14	Negative regulation of viral genome replication
Process	GO:0048525	11	105	9606	OAS3,OASL,ISG20,OAS2,TRIM14,IFIT1,ISG15,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,ISG20,OAS2,TRIM14,IFIT1,ISG15,RSAD2,MX1,IFITM1,OAS1	1.02e-16	7.27e-14	Negative regulation of viral process
Process	GO:0050792	12	215	9606	OAS3,OASL,ISG20,OAS2,TRIM14,IFIT1,ISG15,RSAD2,LGALS9,MX1,IFITM1,OAS1	OAS3,OASL,ISG20,OAS2,TRIM14,IFIT1,ISG15,RSAD2,LGALS9,MX1,IFITM1,OAS1	4.26e-15	2.68e-12	Regulation of viral process
Process	GO:1903900	11	153	9606	OAS3,OASL,ISG20,OAS2,IFIT1,ISG15,RSAD2,LGALS9,MX1,IFITM1,OAS1	OAS3,OASL,ISG20,OAS2,IFIT1,ISG15,RSAD2,LGALS9,MX1,IFITM1,OAS1	5.02e-15	2.93e-12	Regulation of viral life cycle
Process	GO:0071345	18	1013	9606	OAS3,OASL,SAMHD1,TLR3,ISG20,MX2,OAS2,GBP4,GBP1,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,LGALS9,MX1,IFITM1,OAS1	OAS3,OASL,SAMHD1,TLR3,ISG20,MX2,OAS2,GBP4,GBP1,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,LGALS9,MX1,IFITM1,OAS1	3.03e-14	1.62e-11	Cellular response to cytokine stimulus
Process	GO:0019221	15	678	9606	OAS3,OASL,SAMHD1,ISG20,MX2,OAS2,GBP1,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,SAMHD1,ISG20,MX2,OAS2,GBP1,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	4.05e-13	2e-10	Cytokine-mediated signaling pathway
Process	GO:0071310	22	2369	9606	OAS3,CMPK2,OASL,SAMHD1,IFIH1,TLR3,ISG20,MX2,OAS2,CTSS,GBP4,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1	OAS3,CMPK2,OASL,SAMHD1,IFIH1,TLR3,ISG20,MX2,OAS2,CTSS,GBP4,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1	4.94e-12	2.35e-09	Cellular response to organic substance
Process	GO:0034341	9	182	9606	OAS3,OASL,TLR3,OAS2,GBP4,GBP1,LGALS9,IFITM1,OAS1	OAS3,OASL,TLR3,OAS2,GBP4,GBP1,LGALS9,IFITM1,OAS1	4.92e-11	2.18e-08	Response to interferon-gamma
Process	GO:0071346	8	161	9606	OAS3,OASL,TLR3,OAS2,GBP4,GBP1,LGALS9,OAS1	OAS3,OASL,TLR3,OAS2,GBP4,GBP1,LGALS9,OAS1	6.37e-10	2.56e-07	Cellular response to interferon-gamma
Process	GO:0035455	5	23	9606	MX2,IFIT3,IFIT2,IFITM1,OAS1	MX2,IFIT3,IFIT2,IFITM1,OAS1	1.49e-09	5.81e-07	Response to interferon-alpha
Process	GO:0060700	4	9	9606	OAS3,OASL,OAS2,OAS1	OAS3,OASL,OAS2,OAS1	6.77e-09	2.56e-06	Regulation of ribonuclease activity
Process	GO:0071360	4	17	9606	IFIH1,TLR3,IFIT1,DDX58	IFIH1,TLR3,IFIT1,DDX58	5.61e-08	2.06e-05	Cellular response to exogenous dsrna
Process	GO:0034344	3	3	9606	IFIH1,TLR3,DDX58	IFIH1,TLR3,DDX58	1.13e-07	4.05e-05	Regulation of type iii interferon production
Process	GO:0007166	17	2325	9606	OAS3,OASL,SAMHD1,DTX3L,TLR3,ISG20,MX2,OAS2,GBP1,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,SAMHD1,DTX3L,TLR3,ISG20,MX2,OAS2,GBP1,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	1.77e-07	5.83e-05	Cell surface receptor signaling pathway
Process	GO:0060333	5	70	9606	OAS3,OASL,OAS2,GBP1,OAS1	OAS3,OASL,OAS2,GBP1,OAS1	2.46e-07	7.91e-05	Interferon-gamma-mediated signaling pathway
Process	GO:0050896	30	8046	9606	OAS3,CMPK2,OASL,SAMHD1,IFIH1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,TAP1,CTSS,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,PHACTR4,TAP2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14	OAS3,CMPK2,OASL,SAMHD1,IFIH1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,TAP1,CTSS,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,PHACTR4,TAP2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14	2.53e-07	7.94e-05	Response to stimulus
Process	GO:0009597	3	6	9606	IFIH1,TLR3,DDX58	IFIH1,TLR3,DDX58	4.74e-07	0.00015	Detection of virus
Process	GO:0016032	10	776	9606	SP110,SAMHD1,IFIH1,DTX3L,TAP1,IFIT1,TAP2,ISG15,DDX58,RSAD2	SP110,SAMHD1,IFIH1,DTX3L,TAP1,IFIT1,TAP2,ISG15,DDX58,RSAD2	1e-06	0.00029	Viral process
Process	GO:0035457	3	13	9606	IFIT3,IFIT2,OAS1	IFIT3,IFIT2,OAS1	3.13e-06	0.00086	Cellular response to interferon-alpha
Process	GO:0007165	22	4876	9606	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,CTSS,GBP1,IFIT1,IFIT3,IFIT2,PHACTR4,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,CTSS,GBP1,IFIT1,IFIT3,IFIT2,PHACTR4,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1	4.65e-06	0.0012	Signal transduction
Process	GO:0048519	23	5389	9606	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,OAS2,TRIM14,GBP1,IFIT1,IFIT3,PHACTR4,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,HELZ2,PARP14,RNF213	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,OAS2,TRIM14,GBP1,IFIT1,IFIT3,PHACTR4,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,HELZ2,PARP14,RNF213	5.92e-06	0.0015	Negative regulation of biological process
Process	GO:0061025	5	136	9606	MX2,TAP1,TAP2,SAMD9,MX1	MX2,TAP1,TAP2,SAMD9,MX1	5.65e-06	0.0015	Membrane fusion
Process	GO:0032727	3	26	9606	IFIH1,TLR3,DDX58	IFIH1,TLR3,DDX58	2.01e-05	0.0049	Positive regulation of interferon-alpha production
Process	GO:0032760	4	88	9606	IFIH1,TLR3,DDX58,LGALS9	IFIH1,TLR3,DDX58,LGALS9	2.39e-05	0.0056	Positive regulation of tumor necrosis factor production
Process	GO:0032755	4	94	9606	IFIH1,TLR3,DDX58,LGALS9	IFIH1,TLR3,DDX58,LGALS9	3.06e-05	0.0069	Positive regulation of interleukin-6 production
Process	GO:0098586	3	32	9606	IFIH1,DDX58,LGALS9	IFIH1,DDX58,LGALS9	3.58e-05	0.0079	Cellular response to virus
Process	GO:0051716	24	6489	9606	OAS3,CMPK2,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,CTSS,GBP4,GBP1,IFIT1,IFIT3,IFIT2,PHACTR4,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1	OAS3,CMPK2,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,CTSS,GBP4,GBP1,IFIT1,IFIT3,IFIT2,PHACTR4,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1	4.12e-05	0.0088	Cellular response to stimulus
Process	GO:0032728	3	34	9606	IFIH1,TLR3,DDX58	IFIH1,TLR3,DDX58	4.23e-05	0.0089	Positive regulation of interferon-beta production
Process	GO:0046967	2	4	9606	TAP1,TAP2	TAP1,TAP2	4.9e-05	0.0101	Cytosol to endoplasmic reticulum transport
Process	GO:0002682	11	1514	9606	SAMHD1,DTX3L,TLR3,GBP1,IFIT1,ISG15,DDX58,RSAD2,LGALS9,IFITM1,PARP14	SAMHD1,DTX3L,TLR3,GBP1,IFIT1,ISG15,DDX58,RSAD2,LGALS9,IFITM1,PARP14	5.92e-05	0.0121	Regulation of immune system process
Process	GO:0002221	4	125	9606	IFIH1,TLR3,CTSS,DDX58	IFIH1,TLR3,CTSS,DDX58	8.96e-05	0.018	Pattern recognition receptor signaling pathway
Process	GO:1990668	2	6	9606	TAP1,TAP2	TAP1,TAP2	9.12e-05	0.018	Vesicle fusion with endoplasmic reticulum-golgi intermediate compartment (ergic) membrane
Process	GO:0032480	3	45	9606	IFIH1,ISG15,DDX58	IFIH1,ISG15,DDX58	9.3e-05	0.0181	Negative regulation of type i interferon production
Process	GO:0002831	6	406	9606	SAMHD1,DTX3L,IFIT1,DDX58,LGALS9,PARP14	SAMHD1,DTX3L,IFIT1,DDX58,LGALS9,PARP14	9.49e-05	0.0182	Regulation of response to biotic stimulus
Process	GO:0032479	4	130	9606	IFIH1,TLR3,ISG15,DDX58	IFIH1,TLR3,ISG15,DDX58	0.0001	0.0196	Regulation of type i interferon production
Process	GO:0002697	6	418	9606	DTX3L,TLR3,IFIT1,DDX58,RSAD2,LGALS9	DTX3L,TLR3,IFIT1,DDX58,RSAD2,LGALS9	0.00011	0.0207	Regulation of immune effector process
Process	GO:0016185	2	7	9606	MX2,MX1	MX2,MX1	0.00012	0.0215	Synaptic vesicle budding from presynaptic endocytic zone membrane
Process	GO:0009617	7	634	9606	CMPK2,HERC6,TLR3,OAS2,GBP4,ISG15,LGALS9	CMPK2,HERC6,TLR3,OAS2,GBP4,ISG15,LGALS9	0.00014	0.0253	Response to bacterium
Process	GO:0098884	2	8	9606	MX2,MX1	MX2,MX1	0.00015	0.0254	Postsynaptic neurotransmitter receptor internalization
Process	GO:0001818	5	280	9606	IFIH1,GBP1,ISG15,DDX58,LGALS9	IFIH1,GBP1,ISG15,DDX58,LGALS9	0.00016	0.0276	Negative regulation of cytokine production
Process	GO:0032757	3	55	9606	TLR3,DDX58,LGALS9	TLR3,DDX58,LGALS9	0.00016	0.0276	Positive regulation of interleukin-8 production
Process	GO:0039528	2	9	9606	IFIH1,DDX58	IFIH1,DDX58	0.00018	0.0294	Cytoplasmic pattern recognition receptor signaling pathway in response to virus
Process	GO:0050776	8	896	9606	SAMHD1,TLR3,GBP1,DDX58,RSAD2,LGALS9,IFITM1,PARP14	SAMHD1,TLR3,GBP1,DDX58,RSAD2,LGALS9,IFITM1,PARP14	0.00019	0.0305	Regulation of immune response
Process	GO:0060760	3	58	9606	IFIH1,DDX58,PARP14	IFIH1,DDX58,PARP14	0.00019	0.0305	Positive regulation of response to cytokine stimulus
Process	GO:0031347	7	674	9606	SAMHD1,DTX3L,TLR3,IFIT1,DDX58,LGALS9,PARP14	SAMHD1,DTX3L,TLR3,IFIT1,DDX58,LGALS9,PARP14	0.00021	0.0318	Regulation of defense response
Process	GO:0019885	2	10	9606	TAP1,TAP2	TAP1,TAP2	0.00021	0.0327	Antigen processing and presentation of endogenous peptide antigen via mhc class i
Process	GO:0045824	3	61	9606	SAMHD1,LGALS9,PARP14	SAMHD1,LGALS9,PARP14	0.00022	0.0328	Negative regulation of innate immune response
Process	GO:0016050	5	308	9606	MX2,TAP1,TAP2,SAMD9,MX1	MX2,TAP1,TAP2,SAMD9,MX1	0.00025	0.0373	Vesicle organization
Process	GO:0002730	2	12	9606	TLR3,DDX58	TLR3,DDX58	0.00029	0.043	Regulation of dendritic cell cytokine production
Process	GO:0060759	4	175	9606	SAMHD1,IFIH1,DDX58,PARP14	SAMHD1,IFIH1,DDX58,PARP14	0.00032	0.0455	Regulation of response to cytokine stimulus
Component	GO:0042825	2	2	9606	TAP1,TAP2	TAP1,TAP2	1.96e-05	0.0334	TAP complex
Function	GO:0003725	7	75	9606	OAS3,OASL,IFIH1,TLR3,OAS2,DDX58,OAS1	OAS3,OASL,IFIH1,TLR3,OAS2,DDX58,OAS1	1.31e-10	4.23e-07	Double-stranded rna binding
Function	GO:0001730	3	3	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	1.13e-07	0.00015	2-5-oligoadenylate synthetase activity
Function	GO:0097367	17	2226	9606	OAS3,CMPK2,SAMHD1,IFIH1,MX2,OAS2,TAP1,CTSS,GBP4,GBP1,IFI44L,TAP2,DDX58,LGALS9,MX1,OAS1,HELZ2	OAS3,CMPK2,SAMHD1,IFIH1,MX2,OAS2,TAP1,CTSS,GBP4,GBP1,IFI44L,TAP2,DDX58,LGALS9,MX1,OAS1,HELZ2	9.38e-08	0.00015	Carbohydrate derivative binding
Function	GO:0035639	15	1799	9606	OAS3,CMPK2,SAMHD1,IFIH1,MX2,OAS2,TAP1,GBP4,GBP1,IFI44L,TAP2,DDX58,MX1,OAS1,HELZ2	OAS3,CMPK2,SAMHD1,IFIH1,MX2,OAS2,TAP1,GBP4,GBP1,IFI44L,TAP2,DDX58,MX1,OAS1,HELZ2	2.51e-07	0.0002	Purine ribonucleoside triphosphate binding
Function	GO:0000166	16	2119	9606	OAS3,CMPK2,SAMHD1,IFIH1,MX2,OAS2,TAP1,GBP4,GBP1,IFI44L,TAP2,DDX58,MX1,OAS1,HELZ2,PARP14	OAS3,CMPK2,SAMHD1,IFIH1,MX2,OAS2,TAP1,GBP4,GBP1,IFI44L,TAP2,DDX58,MX1,OAS1,HELZ2,PARP14	3.21e-07	0.00021	Nucleotide binding
Function	GO:0003723	14	1649	9606	OAS3,OASL,SAMHD1,PARP12,IFIH1,TLR3,ISG20,OAS2,IFIT1,IFIT3,IFIT2,DDX58,OAS1,HELZ2	OAS3,OASL,SAMHD1,PARP12,IFIH1,TLR3,ISG20,OAS2,IFIT1,IFIT3,IFIT2,DDX58,OAS1,HELZ2	6.01e-07	0.00021	RNA binding
Function	GO:0032555	15	1864	9606	OAS3,CMPK2,SAMHD1,IFIH1,MX2,OAS2,TAP1,GBP4,GBP1,IFI44L,TAP2,DDX58,MX1,OAS1,HELZ2	OAS3,CMPK2,SAMHD1,IFIH1,MX2,OAS2,TAP1,GBP4,GBP1,IFI44L,TAP2,DDX58,MX1,OAS1,HELZ2	3.97e-07	0.00021	Purine ribonucleotide binding
Function	GO:0036094	17	2516	9606	OAS3,CMPK2,SAMHD1,IFIH1,MX2,OAS2,TAP1,GBP4,GBP1,IFI44L,TAP2,DDX58,LGALS9,MX1,OAS1,HELZ2,PARP14	OAS3,CMPK2,SAMHD1,IFIH1,MX2,OAS2,TAP1,GBP4,GBP1,IFI44L,TAP2,DDX58,LGALS9,MX1,OAS1,HELZ2,PARP14	5.54e-07	0.00021	Small molecule binding
Function	GO:0017111	10	760	9606	IFIH1,MX2,TAP1,GBP4,GBP1,TAP2,DDX58,MX1,HELZ2,RNF213	IFIH1,MX2,TAP1,GBP4,GBP1,TAP2,DDX58,MX1,HELZ2,RNF213	8.29e-07	0.00022	Nucleoside-triphosphatase activity
Function	GO:0003824	24	5486	9606	OAS3,CMPK2,OASL,SAMHD1,PARP12,IFIH1,HERC6,DTX3L,ISG20,MX2,OAS2,TRIM14,TAP1,CTSS,GBP4,GBP1,TAP2,DDX58,RSAD2,MX1,OAS1,HELZ2,PARP14,RNF213	OAS3,CMPK2,OASL,SAMHD1,PARP12,IFIH1,HERC6,DTX3L,ISG20,MX2,OAS2,TRIM14,TAP1,CTSS,GBP4,GBP1,TAP2,DDX58,RSAD2,MX1,OAS1,HELZ2,PARP14,RNF213	1.69e-06	0.00037	Catalytic activity
Function	GO:1901363	24	5831	9606	OAS3,CMPK2,OASL,SP110,SAMHD1,PARP12,IFIH1,TLR3,ISG20,MX2,OAS2,TAP1,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,TAP2,DDX58,MX1,OAS1,HELZ2,PARP14	OAS3,CMPK2,OASL,SP110,SAMHD1,PARP12,IFIH1,TLR3,ISG20,MX2,OAS2,TAP1,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,TAP2,DDX58,MX1,OAS1,HELZ2,PARP14	5.51e-06	0.001	Heterocyclic compound binding
Function	GO:0097159	24	5916	9606	OAS3,CMPK2,OASL,SP110,SAMHD1,PARP12,IFIH1,TLR3,ISG20,MX2,OAS2,TAP1,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,TAP2,DDX58,MX1,OAS1,HELZ2,PARP14	OAS3,CMPK2,OASL,SP110,SAMHD1,PARP12,IFIH1,TLR3,ISG20,MX2,OAS2,TAP1,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,TAP2,DDX58,MX1,OAS1,HELZ2,PARP14	7.27e-06	0.0013	Organic cyclic compound binding
Function	GO:0043168	16	2805	9606	OAS3,CMPK2,SAMHD1,IFIH1,MX2,OAS2,TAP1,GBP4,GBP1,IFI44L,TAP2,DDX58,MX1,OAS1,HELZ2,PARP14	OAS3,CMPK2,SAMHD1,IFIH1,MX2,OAS2,TAP1,GBP4,GBP1,IFI44L,TAP2,DDX58,MX1,OAS1,HELZ2,PARP14	1.34e-05	0.0023	Anion binding
Function	GO:0015433	2	3	9606	TAP1,TAP2	TAP1,TAP2	3.27e-05	0.005	ATPase-coupled peptide antigen transmembrane transporter activity
Function	GO:1904680	3	33	9606	SLC15A3,TAP1,TAP2	SLC15A3,TAP1,TAP2	3.9e-05	0.0057	Peptide transmembrane transporter activity
Function	GO:0046978	2	4	9606	TAP1,TAP2	TAP1,TAP2	4.9e-05	0.0069	TAP1 binding
Function	GO:0005525	6	370	9606	SAMHD1,MX2,GBP4,GBP1,IFI44L,MX1	SAMHD1,MX2,GBP4,GBP1,IFI44L,MX1	5.73e-05	0.0074	GTP binding
Function	GO:0043167	23	6188	9606	OAS3,CMPK2,SP110,SAMHD1,PARP12,IFIH1,DTX3L,ISG20,MX2,OAS2,TRIM14,TAP1,GBP4,GBP1,IFI44L,TAP2,DDX58,RSAD2,MX1,OAS1,HELZ2,PARP14,RNF213	OAS3,CMPK2,SP110,SAMHD1,PARP12,IFIH1,DTX3L,ISG20,MX2,OAS2,TRIM14,TAP1,GBP4,GBP1,IFI44L,TAP2,DDX58,RSAD2,MX1,OAS1,HELZ2,PARP14,RNF213	7.02e-05	0.0077	Ion binding
Function	GO:0016887	6	393	9606	IFIH1,TAP1,TAP2,DDX58,HELZ2,RNF213	IFIH1,TAP1,TAP2,DDX58,HELZ2,RNF213	7.96e-05	0.0079	ATPase activity
Function	GO:0016779	4	124	9606	OAS3,OASL,OAS2,OAS1	OAS3,OASL,OAS2,OAS1	8.69e-05	0.008	Nucleotidyltransferase activity
Function	GO:0023029	2	7	9606	TAP1,TAP2	TAP1,TAP2	0.00012	0.0105	MHC class Ib protein binding
Function	GO:0016787	13	2419	9606	SAMHD1,IFIH1,ISG20,MX2,TAP1,CTSS,GBP4,GBP1,TAP2,DDX58,MX1,HELZ2,RNF213	SAMHD1,IFIH1,ISG20,MX2,TAP1,CTSS,GBP4,GBP1,TAP2,DDX58,MX1,HELZ2,RNF213	0.00023	0.0191	Hydrolase activity
Function	GO:0003724	3	74	9606	IFIH1,DDX58,HELZ2	IFIH1,DDX58,HELZ2	0.00038	0.0307	RNA helicase activity
Function	GO:1990404	2	15	9606	PARP12,PARP14	PARP12,PARP14	0.00044	0.0346	Protein adp-ribosylase activity
Function	GO:0140098	5	375	9606	SAMHD1,IFIH1,ISG20,DDX58,HELZ2	SAMHD1,IFIH1,ISG20,DDX58,HELZ2	0.00061	0.0472	Catalytic activity, acting on rna
TISSUES	BTO:0000570	15	2543	9606	SLC15A3,OAS3,OASL,SP110,SAMHD1,IFIH1,HERC6,TLR3,OAS2,TAP1,GBP4,LGALS9,OAS1,HELZ2,RNF213	SLC15A3,OAS3,OASL,SP110,SAMHD1,IFIH1,HERC6,TLR3,OAS2,TAP1,GBP4,LGALS9,OAS1,HELZ2,RNF213	1.94e-05	0.0369	Hematopoietic system
DISEASES	DOID:0060861	6	8	9606	OAS3,OASL,OAS2,DDX58,MX1,OAS1	OAS3,OASL,OAS2,DDX58,MX1,OAS1	7.35e-14	3.21e-10	Microphthalmia with limb anomalies
Keyword	KW-0051	19	127	9606	OAS3,OASL,SAMHD1,IFIH1,DTX3L,ISG20,MX2,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,SAMHD1,IFIH1,DTX3L,ISG20,MX2,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	8.51e-32	5.75e-29	Antiviral defense
Keyword	KW-0391	24	522	9606	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,TAP1,GBP1,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,TAP1,GBP1,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,PARP14	2.65e-29	8.95e-27	Immunity
Keyword	KW-0399	20	324	9606	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1,PARP14	OAS3,OASL,SAMHD1,IFIH1,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1,PARP14	2.5e-26	5.64e-24	Innate immunity
Keyword	KW-0945	10	534	9606	SP110,SAMHD1,IFIH1,DTX3L,TAP1,IFIT1,TAP2,ISG15,DDX58,RSAD2	SP110,SAMHD1,IFIH1,DTX3L,TAP1,IFIT1,TAP2,ISG15,DDX58,RSAD2	3.31e-08	5.6e-06	Host-virus interaction
Keyword	KW-0694	10	670	9606	OAS3,OASL,IFIH1,TLR3,ISG20,OAS2,IFIT1,IFIT2,DDX58,OAS1	OAS3,OASL,IFIH1,TLR3,ISG20,OAS2,IFIT1,IFIT2,DDX58,OAS1	2.65e-07	3.59e-05	RNA-binding
Keyword	KW-0571	3	8	9606	SLC15A3,TAP1,TAP2	SLC15A3,TAP1,TAP2	9.29e-07	0.0001	Peptide transport
Keyword	KW-0547	14	1760	9606	OAS3,CMPK2,SAMHD1,IFIH1,MX2,OAS2,TAP1,GBP4,GBP1,TAP2,DDX58,MX1,OAS1,HELZ2	OAS3,CMPK2,SAMHD1,IFIH1,MX2,OAS2,TAP1,GBP4,GBP1,TAP2,DDX58,MX1,OAS1,HELZ2	1.32e-06	0.00013	Nucleotide-binding
Keyword	KW-0963	23	5028	9606	OAS3,OASL,IFIH1,HERC6,DTX3L,ISG20,MX2,OAS2,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,PHACTR4,ISG15,DDX58,SAMD9,LGALS9,MX1,OAS1,PARP14,RNF213	OAS3,OASL,IFIH1,HERC6,DTX3L,ISG20,MX2,OAS2,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,PHACTR4,ISG15,DDX58,SAMD9,LGALS9,MX1,OAS1,PARP14,RNF213	1.64e-06	0.00014	Cytoplasm
Keyword	KW-0948	2	7	9606	SAMHD1,IFIH1	SAMHD1,IFIH1	0.00012	0.0088	Aicardi-Goutieres syndrome
Keyword	KW-0548	3	69	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	0.00031	0.021	Nucleotidyltransferase
Keyword	KW-0342	5	337	9606	SAMHD1,MX2,GBP4,GBP1,MX1	SAMHD1,MX2,GBP4,GBP1,MX1	0.00038	0.0233	GTP-binding
Keyword	KW-0067	9	1368	9606	OAS3,CMPK2,IFIH1,OAS2,TAP1,TAP2,DDX58,OAS1,HELZ2	OAS3,CMPK2,IFIH1,OAS2,TAP1,TAP2,DDX58,OAS1,HELZ2	0.00067	0.038	ATP-binding
KEGG	hsa05160	9	156	9606	OAS3,TLR3,MX2,OAS2,IFIT1,DDX58,RSAD2,MX1,OAS1	OAS3,TLR3,MX2,OAS2,IFIT1,DDX58,RSAD2,MX1,OAS1	1.32e-11	4.43e-09	Hepatitis C
KEGG	hsa05164	9	165	9606	OAS3,IFIH1,TLR3,MX2,OAS2,DDX58,RSAD2,MX1,OAS1	OAS3,IFIH1,TLR3,MX2,OAS2,DDX58,RSAD2,MX1,OAS1	2.13e-11	4.43e-09	Influenza A
KEGG	hsa05162	7	138	9606	OAS3,IFIH1,MX2,OAS2,DDX58,MX1,OAS1	OAS3,IFIH1,MX2,OAS2,DDX58,MX1,OAS1	7.31e-09	8.19e-07	Measles
KEGG	hsa05169	7	193	9606	OAS3,OAS2,TAP1,TAP2,ISG15,DDX58,OAS1	OAS3,OAS2,TAP1,TAP2,ISG15,DDX58,OAS1	6.73e-08	5.66e-06	Epstein-Barr virus infection
KEGG	hsa05168	8	479	9606	OAS3,IFIH1,TLR3,OAS2,TAP1,TAP2,DDX58,OAS1	OAS3,IFIH1,TLR3,OAS2,TAP1,TAP2,DDX58,OAS1	2.25e-06	0.00015	Herpes simplex virus 1 infection
KEGG	hsa04621	5	174	9606	OAS3,OAS2,GBP4,GBP1,OAS1	OAS3,OAS2,GBP4,GBP1,OAS1	1.8e-05	0.001	NOD-like receptor signaling pathway
KEGG	hsa04612	3	63	9606	TAP1,CTSS,TAP2	TAP1,CTSS,TAP2	0.00024	0.0115	Antigen processing and presentation
KEGG	hsa04622	3	70	9606	IFIH1,ISG15,DDX58	IFIH1,ISG15,DDX58	0.00032	0.0135	RIG-I-like receptor signaling pathway
KEGG	hsa05165	5	325	9606	OASL,TLR3,MX2,ISG15,MX1	OASL,TLR3,MX2,ISG15,MX1	0.00032	0.0135	Human papillomavirus infection
InterPro	IPR006116	4	4	9606	OAS3,OASL,OAS2,OAS1	OAS3,OASL,OAS2,OAS1	6.67e-10	4.52e-06	2-5OAS/ClassI-CCAase, nucleotidyltransferase domain
InterPro	IPR006117	4	4	9606	OAS3,OASL,OAS2,OAS1	OAS3,OASL,OAS2,OAS1	6.67e-10	4.52e-06	2-5-oligoadenylate synthetase, C-terminal  conserved site
InterPro	IPR018952	4	4	9606	OAS3,OASL,OAS2,OAS1	OAS3,OASL,OAS2,OAS1	6.67e-10	4.52e-06	2-5-oligoadenylate synthetase 1, domain 2/C-terminal
InterPro	IPR026774	4	4	9606	OAS3,OASL,OAS2,OAS1	OAS3,OASL,OAS2,OAS1	6.67e-10	4.52e-06	2-5-oligoadenylate synthase
InterPro	IPR027417	13	861	9606	CMPK2,IFIH1,MX2,TAP1,GBP4,GBP1,IFI44L,TAP2,DDX58,SAMD9,MX1,HELZ2,RNF213	CMPK2,IFIH1,MX2,TAP1,GBP4,GBP1,IFI44L,TAP2,DDX58,SAMD9,MX1,HELZ2,RNF213	2.24e-09	4.52e-06	P-loop containing nucleoside triphosphate hydrolase
InterPro	IPR043518	4	4	9606	OAS3,OASL,OAS2,OAS1	OAS3,OASL,OAS2,OAS1	6.67e-10	4.52e-06	2-5-oligoadenylate synthetase, N-terminal conserved site
InterPro	IPR043519	4	23	9606	OAS3,OASL,OAS2,OAS1	OAS3,OASL,OAS2,OAS1	1.63e-07	0.00016	Nucleotidyltransferase superfamily
InterPro	IPR002934	3	7	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	6.77e-07	0.00057	Polymerase, nucleotidyl transferase domain
InterPro	IPR013305	2	3	9606	TAP1,TAP2	TAP1,TAP2	3.27e-05	0.0246	ABC transporter Tap-like
InterPro	IPR021673	2	3	9606	IFIH1,DDX58	IFIH1,DDX58	3.27e-05	0.0246	RIG-I-like receptor, C-terminal regulatory domain
InterPro	IPR031964	2	3	9606	IFIH1,DDX58	IFIH1,DDX58	3.27e-05	0.0246	Caspase recruitment domain
InterPro	IPR038557	2	3	9606	IFIH1,DDX58	IFIH1,DDX58	3.27e-05	0.0246	RIG-I-like receptor, C-terminal domain superfamily
InterPro	IPR041204	2	3	9606	IFIH1,DDX58	IFIH1,DDX58	3.27e-05	0.0246	RIG-I receptor, C-terminal
InterPro	IPR000375	2	6	9606	MX2,MX1	MX2,MX1	9.12e-05	0.0441	Dynamin central domain
InterPro	IPR001401	2	7	9606	MX2,MX1	MX2,MX1	0.00012	0.0441	Dynamin, GTPase domain
InterPro	IPR003130	2	6	9606	MX2,MX1	MX2,MX1	9.12e-05	0.0441	Dynamin GTPase effector
InterPro	IPR019762	2	6	9606	MX2,MX1	MX2,MX1	9.12e-05	0.0441	Dynamin, GTPase region, conserved site
InterPro	IPR020850	2	6	9606	MX2,MX1	MX2,MX1	9.12e-05	0.0441	GTPase effector domain
InterPro	IPR037684	2	7	9606	GBP4,GBP1	GBP4,GBP1	0.00012	0.0441	Guanylate-binding protein, C-terminal
Pfam	PF10421	4	4	9606	OAS3,OASL,OAS2,OAS1	OAS3,OASL,OAS2,OAS1	6.67e-10	2.3e-06	2-5-oligoadenylate synthetase 1, domain 2, C-terminus 
Pfam	PF01909	3	11	9606	OAS3,OAS2,OAS1	OAS3,OAS2,OAS1	2.04e-06	0.0035	Nucleotidyltransferase domain
Pfam	PF11648	2	3	9606	IFIH1,DDX58	IFIH1,DDX58	3.27e-05	0.0375	C-terminal domain of RIG-I
Pfam	PF16739	2	4	9606	IFIH1,DDX58	IFIH1,DDX58	4.9e-05	0.0422	Caspase recruitment domain
PMID	PMID:34771433	19	38	9606	OAS3,OASL,SAMHD1,IFIH1,HERC6,DTX3L,MX2,OAS2,CTSS,IFIT1,IFIT3,IFIT2,ISG15,DDX58,LGALS9,MX1,OAS1,PARP14,RNF213	OAS3,OASL,SAMHD1,IFIH1,HERC6,DTX3L,MX2,OAS2,CTSS,IFIT1,IFIT3,IFIT2,ISG15,DDX58,LGALS9,MX1,OAS1,PARP14,RNF213	1.82e-40	7.18e-34	(2021) Multi-Omics Analysis of Glioblastoma Cells Sensitivity to Oncolytic Viruses.
PMID	PMID:31665046	20	76	9606	OAS3,CMPK2,OASL,PARP12,IFIH1,MX2,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,SAMD9,RSAD2,LGALS9,MX1,OAS1,HELZ2	OAS3,CMPK2,OASL,PARP12,IFIH1,MX2,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,SAMD9,RSAD2,LGALS9,MX1,OAS1,HELZ2	5.21e-38	1.03e-31	(2019) Identifying novel biomarkers of the pediatric influenza infection by weighted co-expression network analysis.
PMID	PMID:23369858	17	50	9606	OAS3,OASL,IFIH1,TLR3,ISG20,OAS2,TRIM14,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,IFITM1,OAS1	OAS3,OASL,IFIH1,TLR3,ISG20,OAS2,TRIM14,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,IFITM1,OAS1	1.06e-33	1.4e-27	(2013) What role (if any) does the highly conserved CSB-PGBD3 fusion protein play in Cockayne syndrome?
PMID	PMID:29215570	17	53	9606	OAS3,OASL,IFIH1,TLR3,ISG20,MX2,OAS2,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,IFIH1,TLR3,ISG20,MX2,OAS2,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	2.48e-33	2.45e-27	(2017) Host Cell Restriction Factors that Limit Influenza A Infection.
PMID	PMID:28805681	18	92	9606	OAS3,OASL,IFIH1,TLR3,ISG20,MX2,OAS2,GBP1,IFIT1,ISG15,DDX58,SAMD9,RSAD2,MX1,IFITM1,OAS1,HELZ2,PARP14	OAS3,OASL,IFIH1,TLR3,ISG20,MX2,OAS2,GBP1,IFIT1,ISG15,DDX58,SAMD9,RSAD2,MX1,IFITM1,OAS1,HELZ2,PARP14	5.9e-32	4.66e-26	(2017) Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis.
PMID	PMID:31937643	15	35	9606	OAS3,CMPK2,OASL,ISG20,MX2,OAS2,GBP4,IFI44L,IFIT1,ISG15,DDX58,RSAD2,MX1,OAS1,RNF213	OAS3,CMPK2,OASL,ISG20,MX2,OAS2,GBP4,IFI44L,IFIT1,ISG15,DDX58,RSAD2,MX1,OAS1,RNF213	6.56e-31	4.32e-25	(2020) Cell-to-Cell Variation in Defective Virus Expression and Effects on Host Responses during Influenza Virus Infection.
PMID	PMID:31465999	16	57	9606	OAS3,OASL,SAMHD1,PARP12,IFIH1,HERC6,MX2,IFIT1,IFIT3,ISG15,DDX58,SAMD9,RSAD2,MX1,OAS1,RNF213	OAS3,OASL,SAMHD1,PARP12,IFIH1,HERC6,MX2,IFIT1,IFIT3,ISG15,DDX58,SAMD9,RSAD2,MX1,OAS1,RNF213	1.62e-30	9.11e-25	(2019) Virus- and Interferon Alpha-Induced Transcriptomes of Cells from the Microbat Myotis daubentonii.
PMID	PMID:34367124	15	41	9606	CMPK2,OASL,IFIH1,ISG20,MX2,OAS2,GBP1,IFI44L,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	CMPK2,OASL,IFIH1,ISG20,MX2,OAS2,GBP1,IFI44L,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	4.71e-30	2.06e-24	(2021) Comprehensive Transcriptomic Analysis Identifies Novel Antiviral Factors Against Influenza A Virus Infection.
PMID	PMID:34372578	18	120	9606	OAS3,OASL,SAMHD1,IFIH1,TLR3,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1,HELZ2	OAS3,OASL,SAMHD1,IFIH1,TLR3,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1,HELZ2	4.67e-30	2.06e-24	(2021) Immunity and Viral Infections: Modulating Antiviral Response via CRISPR-Cas Systems.
PMID	PMID:22483866	16	61	9606	OAS3,OASL,IFIH1,ISG20,OAS2,TRIM14,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,IFITM1,OAS1	OAS3,OASL,IFIH1,ISG20,OAS2,TRIM14,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,IFITM1,OAS1	4.17e-30	2.06e-24	(2012) The conserved Cockayne syndrome B-piggyBac fusion protein (CSB-PGBD3) affects DNA repair and induces both interferon-like and innate antiviral responses in CSB-null cells.
PMID	PMID:31641281	15	42	9606	OAS3,OASL,SAMHD1,IFIH1,HERC6,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,OAS1	OAS3,OASL,SAMHD1,IFIH1,HERC6,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,OAS1	6.39e-30	2.29e-24	(2020) A clinical score to guide in decision making for monogenic type I IFNopathies.
PMID	PMID:33810083	18	127	9606	OAS3,OASL,IFIH1,TLR3,ISG20,MX2,OAS2,TRIM14,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,IFIH1,TLR3,ISG20,MX2,OAS2,TRIM14,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	1.2e-29	3.94e-24	(2021) Mammalian and Avian Host Cell Influenza A Restriction Factors.
PMID	PMID:33276587	15	48	9606	OASL,IFIH1,TLR3,MX2,OAS2,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OASL,IFIH1,TLR3,MX2,OAS2,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	3.51e-29	1.07e-23	(2020) Host Cell Restriction Factors of Paramyxoviruses and Pneumoviruses.
PMID	PMID:28106799	14	32	9606	OAS3,SAMHD1,IFIH1,TLR3,ISG20,MX2,OAS2,CTSS,IFIT1,IFIT3,ISG15,DDX58,MX1,OAS1	OAS3,SAMHD1,IFIH1,TLR3,ISG20,MX2,OAS2,CTSS,IFIT1,IFIT3,ISG15,DDX58,MX1,OAS1	6.24e-29	1.76e-23	(2017) RNA Editing, ADAR1, and the Innate Immune Response.
PMID	PMID:23781071	15	51	9606	SAMHD1,IFIH1,TLR3,ISG20,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	SAMHD1,IFIH1,TLR3,ISG20,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	7.7e-29	2.03e-23	(2013) A short hairpin RNA screen of interferon-stimulated genes identifies a novel negative regulator of the cellular antiviral response.
PMID	PMID:34490145	15	52	9606	OAS3,OASL,IFIH1,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,IFIH1,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	9.91e-29	2.44e-23	(2021) Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Stimulated by Mycobacterium tuberculosis PPE57 Identifies Characteristic Genes Associated With Type I Interferon Signaling.
PMID	PMID:34160465	14	36	9606	OAS3,OASL,SAMHD1,IFIH1,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	OAS3,OASL,SAMHD1,IFIH1,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	2.43e-28	5.64e-23	(2021) Identification of hub genes, pathways, and related transcription factors in systemic lupus erythematosus: A preliminary bioinformatics analysis.
PMID	PMID:30336493	14	36	9606	IFIH1,OAS2,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	IFIH1,OAS2,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	2.43e-28	5.64e-23	(2018) Type 1 interferon-inducible gene expression in QuantiFERON Gold TB-positive uveitis: A tool to stratify a high versus low risk of active tuberculosis?
PMID	PMID:34180358	13	22	9606	OAS3,OASL,IFIH1,OAS2,GBP1,IFI44L,IFIT1,IFIT3,ISG15,DDX58,RSAD2,MX1,OAS1	OAS3,OASL,IFIH1,OAS2,GBP1,IFI44L,IFIT1,IFIT3,ISG15,DDX58,RSAD2,MX1,OAS1	3.3e-28	6.85e-23	(2021) Potential therapeutic target genes for systemic lupus erythematosus: a bioinformatics analysis.
PMID	PMID:30804934	14	38	9606	OAS3,CMPK2,IFIH1,TLR3,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1	OAS3,CMPK2,IFIH1,TLR3,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1	4.57e-28	9.02e-23	(2019) The Long Non-coding RNA NRIR Drives IFN-Response in Monocytes: Implication for Systemic Sclerosis.
PMID	PMID:28701698	17	119	9606	OAS3,OASL,SAMHD1,IFIH1,ISG20,MX2,OAS2,GBP4,GBP1,IFI44L,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,SAMHD1,IFIH1,ISG20,MX2,OAS2,GBP4,GBP1,IFI44L,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	5.47e-28	1.03e-22	(2017) Global Mapping of the Macrophage-HIV-1 Transcriptome Reveals that Productive Infection Induces Remodeling of Host Cell DNA and Chromatin.
PMID	PMID:34880855	13	24	9606	OAS3,OASL,IFIH1,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,IFIH1,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	7.95e-28	1.43e-22	(2021) Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis.
PMID	PMID:32114504	13	25	9606	OAS3,OASL,IFIH1,TLR3,OAS2,IFI44L,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,IFIH1,TLR3,OAS2,IFI44L,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	1.21e-27	2.07e-22	(2020) Efficient acute and chronic infection of stem cell-derived hepatocytes by hepatitis C virus.
PMID	PMID:34559160	14	42	9606	OAS3,OASL,HERC6,ISG20,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,OAS1	OAS3,OASL,HERC6,ISG20,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,OAS1	1.49e-27	2.46e-22	(2021) CXCL10 and its related key genes as potential biomarkers for psoriasis: Evidence from bioinformatics and real-time quantitative polymerase chain reaction.
PMID	PMID:32325933	14	42	9606	IFIH1,TLR3,ISG20,MX2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	IFIH1,TLR3,ISG20,MX2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	1.49e-27	2.46e-22	(2020) RNAseq Reveals the Contribution of Interferon Stimulated Genes to the Increased Host Defense and Decreased PPR Viral Replication in Cattle.
PMID	PMID:26008703	14	43	9606	IFIH1,TLR3,MX2,OAS2,GBP4,GBP1,IFI44L,IFIT1,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	IFIH1,TLR3,MX2,OAS2,GBP4,GBP1,IFI44L,IFIT1,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	1.98e-27	3e-22	(2015) Insights into Human Astrocyte Response to H5N1 Infection by Microarray Analysis.
PMID	PMID:22694362	14	44	9606	OAS3,OASL,SAMHD1,MX2,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,SAMD9,RSAD2,MX1,IFITM1	OAS3,OASL,SAMHD1,MX2,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,SAMD9,RSAD2,MX1,IFITM1	2.6e-27	3.81e-22	(2012) Response of primary human airway epithelial cells to influenza infection: a quantitative proteomic study.
PMID	PMID:32276512	13	28	9606	OAS3,OASL,IFIH1,TLR3,OAS2,IFI44L,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM1,OAS1	OAS3,OASL,IFIH1,TLR3,OAS2,IFI44L,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM1,OAS1	3.91e-27	5.51e-22	(2020) 2, 5-Oligoadenylate Synthetase 2 (OAS2) Inhibits Zika Virus Replication through Activation of Type Iota IFN Signaling Pathway.
PMID	PMID:35262626	16	99	9606	OAS3,OASL,SAMHD1,IFIH1,TLR3,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,SAMHD1,IFIH1,TLR3,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	4.41e-27	6e-22	(2022) DNA damage contributes to neurotoxic inflammation in Aicardi-Goutieres syndrome astrocytes.
PMID	PMID:17257431	16	99	9606	OAS3,OASL,IFIH1,TLR3,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,IFIH1,TLR3,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	4.41e-27	6e-22	(2007) Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream.
PMID	PMID:32899429	17	137	9606	OAS3,CMPK2,OASL,IFIH1,TLR3,ISG20,MX2,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	OAS3,CMPK2,OASL,IFIH1,TLR3,ISG20,MX2,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	5.05e-27	6.43e-22	(2020) LncRNAs in the Type I Interferon Antiviral Response.
PMID	PMID:33142113	15	72	9606	OAS3,IFIH1,TLR3,MX2,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS3,IFIH1,TLR3,MX2,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	7.39e-27	9.12e-22	(2020) Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2.
PMID	PMID:28806913	13	31	9606	OAS3,OASL,IFIH1,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM1,OAS1	OAS3,OASL,IFIH1,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,IFITM1,OAS1	1.15e-26	1.37e-21	(2017) Proteomics informed by transcriptomics for characterising differential cellular susceptibility to Nelson Bay orthoreovirus infection.
PMID	PMID:31635289	15	77	9606	OAS3,CMPK2,OASL,IFIH1,HERC6,TLR3,OAS2,TAP1,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2	OAS3,CMPK2,OASL,IFIH1,HERC6,TLR3,OAS2,TAP1,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2	1.83e-26	2.12e-21	(2019) An Acute Stress Model in New Zealand White Rabbits Exhibits Altered Immune Response to Infection with West Nile Virus.
PMID	PMID:35047003	14	53	9606	OAS3,HERC6,TLR3,ISG20,MX2,OAS2,IFI44L,IFIT1,IFIT3,ISG15,RSAD2,MX1,IFITM1,OAS1	OAS3,HERC6,TLR3,ISG20,MX2,OAS2,IFI44L,IFIT1,IFIT3,ISG15,RSAD2,MX1,IFITM1,OAS1	2.49e-26	2.81e-21	(2021) Exploring the Differences in Molecular Mechanisms and Key Biomarkers Between Membranous Nephropathy and Lupus Nephritis Using Integrated Bioinformatics Analysis.
PMID	PMID:34818375	12	19	9606	OAS3,OASL,IFIH1,MX2,OAS2,IFI44L,IFIT3,ISG15,DDX58,RSAD2,MX1,OAS1	OAS3,OASL,IFIH1,MX2,OAS2,IFI44L,IFIT3,ISG15,DDX58,RSAD2,MX1,OAS1	2.58e-26	2.83e-21	(2021) Ten genes are considered as potential biomarkers for the diagnosis of dermatomyositis.
PMID	PMID:22703193	15	79	9606	SAMHD1,IFIH1,TLR3,ISG20,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	SAMHD1,IFIH1,TLR3,ISG20,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	2.59e-26	2.83e-21	(2012) Transcriptome analysis of the interferon-signature defining the autoimmune process of Sjoegrens syndrome.
PMID	PMID:34140575	13	34	9606	OAS3,OASL,ISG20,MX2,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1	OAS3,OASL,ISG20,MX2,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1	3.1e-26	3.22e-21	(2021) Remodeling of bronchial epithelium caused by asthmatic inflammation affects its response to rhinovirus infection.
PMID	PMID:35075430	13	35	9606	OAS3,OASL,IFIH1,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,OAS1	OAS3,OASL,IFIH1,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,OAS1	4.25e-26	4.3e-21	(2022) Bioinformatic Analysis Identifies Biomarkers and Treatment Targets in Primary Sjoegrens Syndrome Patients with Fatigue.
PMID	PMID:27870591	15	82	9606	CMPK2,IFIH1,TLR3,TRIM14,GBP4,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	CMPK2,IFIH1,TLR3,TRIM14,GBP4,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	4.3e-26	4.3e-21	(2017) Human transcriptome response to immunization with live-attenuated Venezuelan equine encephalitis virus vaccine (TC-83): Analysis of whole blood.
PMID	PMID:27444640	15	82	9606	OAS3,OASL,IFIH1,TLR3,ISG20,MX2,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM1,OAS1	OAS3,OASL,IFIH1,TLR3,ISG20,MX2,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM1,OAS1	4.3e-26	4.3e-21	(2016) Transcriptome sequencing wide functional analysis of human mesenchymal stem cells in response to TLR4 ligand.
PMID	PMID:30186768	15	85	9606	PARP12,IFIH1,TLR3,ISG20,MX2,OAS2,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	PARP12,IFIH1,TLR3,ISG20,MX2,OAS2,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	7.02e-26	6.6e-21	(2018) Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance.
PMID	PMID:23847613	14	58	9606	SAMHD1,IFIH1,TLR3,ISG20,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,DDX58,RSAD2,MX1,IFITM1,OAS1	SAMHD1,IFIH1,TLR3,ISG20,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,DDX58,RSAD2,MX1,IFITM1,OAS1	7.56e-26	6.94e-21	(2013) The Interferon-Signature of Sjoegrens Syndrome: How Unique Biomarkers Can Identify Underlying Inflammatory and Immunopathological Mechanisms of Specific Diseases.
PMID	PMID:32164778	13	37	9606	OAS3,OASL,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	7.81e-26	7e-21	(2020) Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis.
PMID	PMID:25377889	13	37	9606	OASL,IFIH1,HERC6,ISG20,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	OASL,IFIH1,HERC6,ISG20,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	7.81e-26	7e-21	(2014) Lassa and Marburg viruses elicit distinct host transcriptional responses early after infection.
PMID	PMID:32978242	15	87	9606	OAS3,CMPK2,OASL,IFIH1,ISG20,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1	OAS3,CMPK2,OASL,IFIH1,ISG20,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1	9.65e-26	8.28e-21	(2020) The myeloid type I interferon response to myocardial infarction begins in bone marrow and is regulated by Nrf2-activated macrophages.
PMID	PMID:25902143	13	39	9606	OAS3,CMPK2,OASL,SAMHD1,HERC6,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1	OAS3,CMPK2,OASL,SAMHD1,HERC6,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1	1.39e-25	1.17e-20	(2015) Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide.
PMID	PMID:21886832	13	39	9606	OASL,IFIH1,ISG20,OAS2,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,DDX58,MX1,IFITM1	OASL,IFIH1,ISG20,OAS2,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,DDX58,MX1,IFITM1	1.39e-25	1.17e-20	(2011) Hepatitis C virus infection suppresses the interferon response in the liver of the human hepatocyte chimeric mouse.
PMID	PMID:35502341	12	23	9606	PARP12,IFIH1,HERC6,MX2,IFI44L,IFIT3,IFIT2,DDX58,RSAD2,MX1,IFITM1,OAS1	PARP12,IFIH1,HERC6,MX2,IFI44L,IFIT3,IFIT2,DDX58,RSAD2,MX1,IFITM1,OAS1	1.52e-25	1.22e-20	(2022) Potential Small Molecules for Therapy of Lupus Nephritis Based on Genetic Effect and Immune Infiltration.
PMID	PMID:30400182	14	62	9606	OAS3,IFIH1,TLR3,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,PARP14	OAS3,IFIH1,TLR3,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1,PARP14	1.73e-25	1.37e-20	(2018) Transcriptomics Reveal Antiviral Gene Induction in the Egyptian Rousette Bat Is Antagonized In Vitro by Marburg Virus Infection.
PMID	PMID:27479908	15	92	9606	OAS3,CMPK2,OASL,IFIH1,MX2,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	OAS3,CMPK2,OASL,IFIH1,MX2,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	2.08e-25	1.61e-20	(2016) Tensor decomposition for multiple-tissue gene expression experiments.
PMID	PMID:24380850	12	24	9606	OAS3,OASL,OAS2,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1	OAS3,OASL,OAS2,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,OAS1	2.28e-25	1.73e-20	(2014) Divergent gene expression responses to complicated grief and non-complicated grief.
PMID	PMID:30949159	16	130	9606	OAS3,OASL,SAMHD1,IFIH1,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,SAMHD1,IFIH1,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	2.48e-25	1.85e-20	(2019) Single-Cell Transcriptome Analysis of CD34(+) Stem Cell-Derived Myeloid Cells Infected With Human Cytomegalovirus.
PMID	PMID:33968942	14	64	9606	OAS3,SAMHD1,ISG20,MX2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,SAMD9,MX1,IFITM1	OAS3,SAMHD1,ISG20,MX2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,SAMD9,MX1,IFITM1	2.57e-25	1.88e-20	(2021) Crosstalk Between SUMO and Ubiquitin-Like Proteins: Implication for Antiviral Defense.
PMID	PMID:32162777	14	65	9606	OAS3,OASL,IFIH1,ISG20,MX2,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM1,OAS1	OAS3,OASL,IFIH1,ISG20,MX2,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM1,OAS1	3.12e-25	2.24e-20	(2020) TLR4-dependent shaping of the wound site by MSCs accelerates wound healing.
PMID	PMID:24713352	13	42	9606	OAS3,SAMHD1,IFIH1,TLR3,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	OAS3,SAMHD1,IFIH1,TLR3,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	3.17e-25	2.24e-20	(2014) Interferon-stimulated genes: roles in viral pathogenesis.
PMID	PMID:25128762	16	135	9606	OAS3,OASL,SAMHD1,IFIH1,HERC6,TLR3,OAS2,IFI44L,IFIT1,IFIT3,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,SAMHD1,IFIH1,HERC6,TLR3,OAS2,IFI44L,IFIT1,IFIT3,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	4.36e-25	3.02e-20	(2014) Virus-host mucosal interactions during early SIV rectal transmission.
PMID	PMID:35139383	13	44	9606	OAS3,OASL,IFIH1,TLR3,OAS2,IFIT1,IFIT3,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,IFIH1,TLR3,OAS2,IFIT1,IFIT3,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	5.34e-25	3.64e-20	(2022) Transcriptome-wide changes in gene expression, splicing, and lncRNAs in response to a live attenuated dengue virus vaccine.
PMID	PMID:33560295	14	68	9606	OAS3,OASL,PARP12,IFIH1,HERC6,OAS2,IFI44L,IFIT1,IFIT2,ISG15,SAMD9,RSAD2,MX1,OAS1	OAS3,OASL,PARP12,IFIH1,HERC6,OAS2,IFI44L,IFIT1,IFIT2,ISG15,SAMD9,RSAD2,MX1,OAS1	5.5e-25	3.68e-20	(2021) An OMICs based meta-analysis to support infection state stratification.
PMID	PMID:30135954	14	69	9606	CMPK2,OASL,IFIH1,TLR3,ISG20,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1	CMPK2,OASL,IFIH1,TLR3,ISG20,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1	6.61e-25	4.35e-20	(2018) Long Non-Coding RNA-Mediated Regulation of the Interferon Response: A New Perspective on a Familiar Theme.
PMID	PMID:24643046	14	69	9606	IFIH1,HERC6,DTX3L,TLR3,ISG20,OAS2,GBP1,IFIT1,ISG15,RSAD2,MX1,IFITM1,OAS1,PARP14	IFIH1,HERC6,DTX3L,TLR3,ISG20,OAS2,GBP1,IFIT1,ISG15,RSAD2,MX1,IFITM1,OAS1,PARP14	6.61e-25	4.35e-20	(2014) RNA-sequence analysis of primary alveolar macrophages after in vitro infection with porcine reproductive and respiratory syndrome virus strains of differing virulence.
PMID	PMID:26682989	12	27	9606	OAS3,OASL,PARP12,IFIH1,HERC6,OAS2,GBP1,IFI44L,IFIT1,RSAD2,MX1,OAS1	OAS3,OASL,PARP12,IFIH1,HERC6,OAS2,GBP1,IFI44L,IFIT1,RSAD2,MX1,OAS1	7.09e-25	4.51e-20	(2015) Integrated, Multi-cohort Analysis Identifies Conserved Transcriptional Signatures across Multiple Respiratory Viruses.
PMID	PMID:20709292	15	101	9606	OAS3,CMPK2,MX2,OAS2,GBP4,GBP1,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,LGALS9,MX1,PARP14,RNF213	OAS3,CMPK2,MX2,OAS2,GBP4,GBP1,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,LGALS9,MX1,PARP14,RNF213	7.51e-25	4.7e-20	(2010) Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gamma.
PMID	PMID:28993767	17	188	9606	OAS3,OASL,IFIH1,TLR3,ISG20,MX2,OAS2,GBP4,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1	OAS3,OASL,IFIH1,TLR3,ISG20,MX2,OAS2,GBP4,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1	7.88e-25	4.86e-20	(2017) Genomic Programming of Human Neonatal Dendritic Cells in Congenital Systemic and In Vitro Cytomegalovirus Infection Reveal Plastic and Robust Immune Pathway Biology Responses.
PMID	PMID:24065129	12	29	9606	OAS3,OASL,IFIH1,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM1,OAS1	OAS3,OASL,IFIH1,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,MX1,IFITM1,OAS1	1.43e-24	8.67e-20	(2013) IFNbeta-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage.
PMID	PMID:23894549	13	49	9606	OAS3,OASL,IFIH1,ISG20,OAS2,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1	OAS3,OASL,IFIH1,ISG20,OAS2,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,MX1	1.8e-24	1.08e-19	(2013) Epstein-Barr virus encoded dUTPase containing exosomes modulate innate and adaptive immune responses in human dendritic cells and peripheral blood mononuclear cells.
PMID	PMID:33253099	11	16	9606	OAS3,OASL,IFIH1,MX2,OAS2,IFI44L,IFIT1,ISG15,RSAD2,MX1,OAS1	OAS3,OASL,IFIH1,MX2,OAS2,IFI44L,IFIT1,ISG15,RSAD2,MX1,OAS1	1.87e-24	1.1e-19	(2021) Increased expression of interferon regulated and antiviral response genes in CD31+CD102+ lung microvascular endothelial cells from systemic sclerosis patients with end-stage interstitial lung disease.
PMID	PMID:24528865	12	30	9606	HERC6,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	HERC6,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	2e-24	1.16e-19	(2014) Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness.
PMID	PMID:34904133	13	51	9606	OAS3,OASL,HERC6,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,OAS1	OAS3,OASL,HERC6,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,OAS1	2.85e-24	1.63e-19	(2022) Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adults.
PMID	PMID:32508817	13	51	9606	OAS3,OASL,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	2.85e-24	1.63e-19	(2020) Contrasting Inflammatory Signatures in Peripheral Blood and Bronchoalveolar Cells Reveal Compartment-Specific Effects of HIV Infection.
PMID	PMID:29475453	13	51	9606	OASL,IFIH1,TLR3,OAS2,GBP4,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1	OASL,IFIH1,TLR3,OAS2,GBP4,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1	2.85e-24	1.63e-19	(2018) Whole transcriptome analysis reveals differential gene expression profile reflecting macrophage polarization in response to influenza A H5N1 virus infection.
PMID	PMID:23299892	13	51	9606	OAS3,PARP12,IFIH1,HERC6,OAS2,IFI44L,IFIT3,IFIT2,ISG15,RSAD2,MX1,OAS1,HELZ2	OAS3,PARP12,IFIH1,HERC6,OAS2,IFI44L,IFIT3,IFIT2,ISG15,RSAD2,MX1,OAS1,HELZ2	2.85e-24	1.63e-19	(2013) Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans.
PMID	PMID:33922087	14	80	9606	OAS3,OASL,IFIH1,HERC6,MX2,OAS2,IFI44L,IFIT1,IFIT3,ISG15,DDX58,MX1,IFITM1,OAS1	OAS3,OASL,IFIH1,HERC6,MX2,OAS2,IFI44L,IFIT1,IFIT3,ISG15,DDX58,MX1,IFITM1,OAS1	4.31e-24	2.33e-19	(2021) Functional Interfaces, Biological Pathways, and Regulations of Interferon-Related DNA Damage Resistance Signature (IRDS) Genes.
PMID	PMID:34527935	13	53	9606	CMPK2,PARP12,IFIH1,OAS2,GBP1,IFI44L,IFIT3,IFIT2,DDX58,OAS1,HELZ2,PARP14,RNF213	CMPK2,PARP12,IFIH1,OAS2,GBP1,IFI44L,IFIT3,IFIT2,DDX58,OAS1,HELZ2,PARP14,RNF213	4.42e-24	2.36e-19	(2021) Investigation of Genes Associated With Atherosclerosis in Patients With Systemic Lupus Erythematosus.
PMID	PMID:32252809	12	33	9606	OAS3,OASL,IFIH1,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,OAS1	OAS3,OASL,IFIH1,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,OAS1	5.18e-24	2.72e-19	(2020) Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
PMID	PMID:34945765	13	54	9606	OAS3,CMPK2,OASL,IFIH1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,PARP14	OAS3,CMPK2,OASL,IFIH1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,PARP14	5.48e-24	2.84e-19	(2021) Personal Network Inference Unveils Heterogeneous Immune Response Patterns to Viral Infection in Children with Acute Wheezing.
PMID	PMID:35197461	15	118	9606	OASL,IFIH1,ISG20,MX2,OAS2,GBP4,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1	OASL,IFIH1,ISG20,MX2,OAS2,GBP4,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1	6.51e-24	3.34e-19	(2022) Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection.
PMID	PMID:18648529	14	83	9606	OAS3,OASL,HERC6,MX2,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	OAS3,OASL,HERC6,MX2,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	6.89e-24	3.49e-19	(2008) Type I interferon: potential therapeutic target for psoriasis?
PMID	PMID:30072977	14	85	9606	CMPK2,OASL,IFIH1,TLR3,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	CMPK2,OASL,IFIH1,TLR3,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	9.35e-24	4.67e-19	(2018) Long Non-coding RNAs: Regulators of Viral Infection and the Interferon Antiviral Response.
PMID	PMID:35235083	11	20	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	1.21e-23	5.98e-19	(2022) Identification of the Hub Genes and the Signaling Pathways in Human iPSC-Cardiomyocytes Infected by SARS-CoV-2.
PMID	PMID:33936072	16	169	9606	SLC15A3,OAS3,OASL,IFIH1,ISG20,MX2,OAS2,GBP1,IFI44L,IFIT1,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	SLC15A3,OAS3,OASL,IFIH1,ISG20,MX2,OAS2,GBP1,IFI44L,IFIT1,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	1.27e-23	6.18e-19	(2021) Single-Cell RNA Sequencing Analysis of the Immunometabolic Rewiring and Immunopathogenesis of Coronavirus Disease 2019.
PMID	PMID:28804651	13	59	9606	OAS3,OASL,ISG20,OAS2,TAP1,GBP1,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,OAS1	OAS3,OASL,ISG20,OAS2,TAP1,GBP1,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,OAS1	1.52e-23	7.33e-19	(2017) Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives.
PMID	PMID:35086375	12	37	9606	OAS3,OASL,IFIH1,HERC6,ISG20,MX2,OAS2,IFI44L,IFIT1,ISG15,MX1,OAS1	OAS3,OASL,IFIH1,HERC6,ISG20,MX2,OAS2,IFI44L,IFIT1,ISG15,MX1,OAS1	1.65e-23	7.86e-19	(2022) Integrated analysis of differentially expressed genes, differentially methylated genes, and natural compounds in hepatitis C virus-induced cirrhosis.
PMID	PMID:30078389	12	38	9606	OAS3,OASL,IFIH1,TLR3,ISG20,OAS2,GBP4,GBP1,IFIT1,ISG15,DDX58,OAS1	OAS3,OASL,IFIH1,TLR3,ISG20,OAS2,GBP4,GBP1,IFIT1,ISG15,DDX58,OAS1	2.17e-23	1.02e-18	(2019) OAS1 and OAS3 negatively regulate the expression of chemokines and interferon-responsive genes in human macrophages.
PMID	PMID:34267761	13	61	9606	CMPK2,OASL,IFIH1,ISG20,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2	CMPK2,OASL,IFIH1,ISG20,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2	2.24e-23	1.04e-18	(2021) Comparative Proteomic Analysis of Polarized Human THP-1 and Mouse RAW264.7 Macrophages.
PMID	PMID:34733317	14	91	9606	CMPK2,IFIH1,TLR3,ISG20,MX2,OAS2,GBP4,IFI44L,IFIT3,ISG15,DDX58,RSAD2,MX1,PARP14	CMPK2,IFIH1,TLR3,ISG20,MX2,OAS2,GBP4,IFI44L,IFIT3,ISG15,DDX58,RSAD2,MX1,PARP14	2.24e-23	1.04e-18	(2021) Integrated Network Analysis to Identify Key Modules and Potential Hub Genes Involved in Bovine Respiratory Disease: A Systems Biology Approach.
PMID	PMID:30621583	14	92	9606	TLR3,ISG20,MX2,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	TLR3,ISG20,MX2,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	2.58e-23	1.17e-18	(2019) Bacterial and viral pathogen-associated molecular patterns induce divergent early transcriptomic landscapes in a bovine macrophage cell line.
PMID	PMID:19646728	13	63	9606	TLR3,ISG20,MX2,OAS2,GBP1,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	TLR3,ISG20,MX2,OAS2,GBP1,IFIT1,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	3.27e-23	1.46e-18	(2009) TLR3 and TLR4 are innate antiviral immune receptors in human microglia: role of IRF3 in modulating antiviral and inflammatory response in the CNS.
PMID	PMID:33290632	12	40	9606	OAS3,CMPK2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS3,CMPK2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	3.69e-23	1.63e-18	(2021) G-quadruplex-forming nucleic acids interact with splicing factor 3B subunit 2 and suppress innate immune gene expression.
PMID	PMID:31611566	12	40	9606	IFIH1,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	IFIH1,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	3.69e-23	1.63e-18	(2019) Experimental challenge with bovine respiratory syncytial virus in dairy calves: bronchial lymph node transcriptome response.
PMID	PMID:29497123	12	40	9606	IFIH1,TLR3,OAS2,TRIM14,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	IFIH1,TLR3,OAS2,TRIM14,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1	3.69e-23	1.63e-18	(2018) Functional innate immunity restricts Hepatitis C Virus infection in induced pluripotent stem cell-derived hepatocytes.
PMID	PMID:29880853	13	64	9606	IFIH1,TLR3,ISG20,MX2,IFI44L,IFIT1,IFIT3,ISG15,DDX58,MX1,IFITM1,OAS1,PARP14	IFIH1,TLR3,ISG20,MX2,IFI44L,IFIT1,IFIT3,ISG15,DDX58,MX1,IFITM1,OAS1,PARP14	3.92e-23	1.68e-18	(2018) Immunoprofiles of human Sertoli cells infected with Zika virus reveals unique insights into host-pathogen crosstalk.
PMID	PMID:26943956	11	23	9606	OAS3,OASL,ISG20,OAS2,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,OAS1	OAS3,OASL,ISG20,OAS2,IFI44L,IFIT1,IFIT2,ISG15,RSAD2,MX1,OAS1	4.08e-23	1.73e-18	(2016) A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients.
PMID	PMID:34552595	13	65	9606	OAS3,OASL,TLR3,MX2,OAS2,GBP4,GBP1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	OAS3,OASL,TLR3,MX2,OAS2,GBP4,GBP1,IFIT3,IFIT2,ISG15,DDX58,MX1,OAS1	4.7e-23	1.97e-18	(2021) Tissue-Resident-Memory CD8(+) T Cells Bridge Innate Immune Responses in Neighboring Epithelial Cells to Control Human Genital Herpes.
PMID	PMID:29724035	14	97	9606	OAS3,IFIH1,HERC6,TLR3,ISG20,OAS2,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,LGALS9,MX1	OAS3,IFIH1,HERC6,TLR3,ISG20,OAS2,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,LGALS9,MX1	5.1e-23	2.12e-18	(2018) Involvement of Pro-Inflammatory Macrophages in Liver Pathology of Pirital Virus-Infected Syrian Hamsters.
PMID	PMID:34876791	11	24	9606	OAS3,IFIH1,MX2,OAS2,TRIM14,IFI44L,IFIT1,IFIT3,IFIT2,MX1,IFITM1	OAS3,IFIH1,MX2,OAS2,TRIM14,IFI44L,IFIT1,IFIT3,IFIT2,MX1,IFITM1	5.94e-23	2.44e-18	(2021) Fusobacterium nucleatum colonization is associated with decreased survival of helicobacter pylori-positive gastric cancer patients.
PMID	PMID:26859759	11	24	9606	IFIH1,ISG20,MX2,OAS2,IFIT1,IFIT2,ISG15,DDX58,MX1,IFITM1,OAS1	IFIH1,ISG20,MX2,OAS2,IFIT1,IFIT2,ISG15,DDX58,MX1,IFITM1,OAS1	5.94e-23	2.44e-18	(2016) Newcastle Disease Virus V Protein Targets Phosphorylated STAT1 to Block IFN-I Signaling.
PMID	PMID:30915053	12	42	9606	SAMHD1,IFIH1,TLR3,ISG20,MX2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1	SAMHD1,IFIH1,TLR3,ISG20,MX2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1	6.11e-23	2.46e-18	(2019) Comparative Description of the Expression Profile of Interferon-Stimulated Genes in Multiple Cell Lineages Targeted by HIV-1 Infection.
PMID	PMID:29947965	11	25	9606	OAS3,IFIH1,HERC6,OAS2,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1	OAS3,IFIH1,HERC6,OAS2,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1	8.55e-23	3.41e-18	(2018) Of mice and men: the host response to influenza virus infection.
PMID	PMID:33062604	13	69	9606	OAS3,CMPK2,OASL,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	OAS3,CMPK2,OASL,OAS2,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	9.47e-23	3.74e-18	(2020) Transcriptome Changes in Colorectal Cancer Cells upon Treatment with Avicequinone B.
RCTM	HSA-913531	18	196	9606	OAS3,OASL,SAMHD1,ISG20,MX2,OAS2,TRIM14,GBP4,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,SAMHD1,ISG20,MX2,OAS2,TRIM14,GBP4,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,IFITM1,OAS1	1.79e-26	3.89e-23	Interferon Signaling
RCTM	HSA-909733	14	69	9606	OAS3,OASL,SAMHD1,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	OAS3,OASL,SAMHD1,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,IFITM1,OAS1	6.61e-25	7.18e-22	Interferon alpha/beta signaling
RCTM	HSA-168256	27	1956	9606	OAS3,OASL,SAMHD1,IFIH1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,TAP1,CTSS,GBP4,GBP1,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,RNF213	OAS3,OASL,SAMHD1,IFIH1,HERC6,DTX3L,TLR3,ISG20,MX2,OAS2,TRIM14,TAP1,CTSS,GBP4,GBP1,IFIT1,IFIT3,IFIT2,TAP2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1,RNF213	4.41e-20	3.19e-17	Immune System
RCTM	HSA-1280215	19	681	9606	OAS3,OASL,SAMHD1,ISG20,MX2,OAS2,TRIM14,GBP4,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1	OAS3,OASL,SAMHD1,ISG20,MX2,OAS2,TRIM14,GBP4,GBP1,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,LGALS9,MX1,IFITM1,OAS1	1.22e-18	6.62e-16	Cytokine Signaling in Immune system
RCTM	HSA-1169410	9	81	9606	OAS3,OASL,MX2,OAS2,IFIT1,ISG15,DDX58,MX1,OAS1	OAS3,OASL,MX2,OAS2,IFIT1,ISG15,DDX58,MX1,OAS1	5.12e-14	2.22e-11	Antiviral mechanism by IFN-stimulated genes
RCTM	HSA-8983711	5	9	9606	OAS3,OASL,OAS2,DDX58,OAS1	OAS3,OASL,OAS2,DDX58,OAS1	3.09e-11	1.12e-08	OAS antiviral response
RCTM	HSA-877300	7	88	9606	OAS3,OASL,OAS2,TRIM14,GBP4,GBP1,OAS1	OAS3,OASL,OAS2,TRIM14,GBP4,GBP1,OAS1	3.73e-10	1.16e-07	Interferon gamma signaling
RCTM	HSA-1169408	5	73	9606	MX2,IFIT1,ISG15,DDX58,MX1	MX2,IFIT1,ISG15,DDX58,MX1	3e-07	8.14e-05	ISG15 antiviral mechanism
RCTM	HSA-936440	3	33	9606	IFIH1,ISG15,DDX58	IFIH1,ISG15,DDX58	3.9e-05	0.0094	Negative regulators of DDX58/IFIH1 signaling
RCTM	HSA-983169	6	366	9606	HERC6,DTX3L,TAP1,CTSS,TAP2,RNF213	HERC6,DTX3L,TAP1,CTSS,TAP2,RNF213	5.4e-05	0.0117	Class I MHC mediated antigen processing & presentation
WikiPathways	WP4197	6	23	9606	TAP1,IFIT1,IFIT3,MX1,IFITM1,OAS1	TAP1,IFIT1,IFIT3,MX1,IFITM1,OAS1	1.14e-11	7.73e-09	Immune response to tuberculosis
WikiPathways	WP4868	6	31	9606	OAS3,IFIH1,TLR3,OAS2,DDX58,OAS1	OAS3,IFIH1,TLR3,OAS2,DDX58,OAS1	5.52e-11	1.87e-08	Type I interferon induction and signaling during SARS-CoV-2 infection
WikiPathways	WP4880	5	33	9606	OAS3,IFIH1,OAS2,DDX58,OAS1	OAS3,IFIH1,OAS2,DDX58,OAS1	7.52e-09	1.7e-06	Host-pathogen interaction of human coronaviruses - interferon induction
WikiPathways	WP619	5	37	9606	TAP1,GBP1,IFIT2,ISG15,OAS1	TAP1,GBP1,IFIT2,ISG15,OAS1	1.27e-08	2.15e-06	Type II interferon signaling (IFNG)
WikiPathways	WP4705	4	16	9606	SAMHD1,IFIH1,DDX58,OAS1	SAMHD1,IFIH1,DDX58,OAS1	4.54e-08	6.16e-06	Pathways of nucleic acid metabolism and innate immune sensing
WikiPathways	WP5039	4	66	9606	IFIT2,DDX58,MX1,IFITM1	IFIT2,DDX58,MX1,IFITM1	8.06e-06	0.00091	SARS-CoV-2 innate immunity evasion and cell-specific immune response
WikiPathways	WP4341	4	71	9606	OAS2,IFI44L,ISG15,RSAD2	OAS2,IFI44L,ISG15,RSAD2	1.06e-05	0.001	Non-genomic actions of 1,25 dihydroxyvitamin D3
WikiPathways	WP4912	3	31	9606	IFIH1,TLR3,DDX58	IFIH1,TLR3,DDX58	3.27e-05	0.0028	SARS coronavirus and innate immunity
WikiPathways	WP5038	3	32	9606	IFIH1,TLR3,DDX58	IFIH1,TLR3,DDX58	3.58e-05	0.0028	Mitochondrial immune response to SARS-CoV-2
WikiPathways	WP3865	3	59	9606	IFIH1,ISG15,DDX58	IFIH1,ISG15,DDX58	0.0002	0.0135	Novel intracellular components of RIG-I-like receptor (RLR) pathway
HPO	HP:0030355	3	15	9606	SP110,SAMHD1,IFIH1	SP110,SAMHD1,IFIH1	4.55e-06	0.0452	Abnormal serum interferon-gamma level
NetworkNeighborAL	CL:19379	24	83	9606	OAS3,OASL,SP110,SAMHD1,PARP12,IFIH1,HERC6,DTX3L,ISG20,MX2,OAS2,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1,PARP14,RNF213	OAS3,OASL,SP110,SAMHD1,PARP12,IFIH1,HERC6,DTX3L,ISG20,MX2,OAS2,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1,PARP14,RNF213	3.63e-47	1.26e-43	Mixed, incl. interferon alpha/beta signaling, and negative regulation of type i interferon production
NetworkNeighborAL	CL:19385	23	61	9606	OAS3,OASL,SP110,PARP12,IFIH1,HERC6,DTX3L,ISG20,MX2,OAS2,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1,PARP14,RNF213	OAS3,OASL,SP110,PARP12,IFIH1,HERC6,DTX3L,ISG20,MX2,OAS2,GBP4,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,DDX58,RSAD2,MX1,OAS1,PARP14,RNF213	2.78e-47	1.26e-43	Interferon alpha/beta signaling, and Negative regulators of DDX58/IFIH1 signaling
NetworkNeighborAL	CL:19389	20	42	9606	OAS3,OASL,SP110,PARP12,HERC6,DTX3L,ISG20,MX2,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,OAS1,PARP14,RNF213	OAS3,OASL,SP110,PARP12,HERC6,DTX3L,ISG20,MX2,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,OAS1,PARP14,RNF213	2.28e-42	2.07e-39	Interferon alpha/beta signaling, and ISG15-protein conjugation
NetworkNeighborAL	CL:19391	15	36	9606	OAS3,OASL,HERC6,ISG20,MX2,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,OAS1	OAS3,OASL,HERC6,ISG20,MX2,OAS2,GBP1,IFI44L,IFIT1,IFIT3,IFIT2,ISG15,RSAD2,MX1,OAS1	9.29e-31	7.03e-28	Interferon alpha/beta signaling, and ISG15-protein conjugation
NetworkNeighborAL	CL:19397	11	16	9606	OAS3,OASL,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,RSAD2,MX1,OAS1	OAS3,OASL,ISG20,MX2,OAS2,IFIT1,IFIT3,IFIT2,RSAD2,MX1,OAS1	1.87e-24	1.22e-21	Microphthalmia with limb anomalies, and Interferon alpha/beta signaling
NetworkNeighborAL	CL:19399	8	11	9606	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,RSAD2,OAS1	OAS3,MX2,OAS2,IFIT1,IFIT3,IFIT2,RSAD2,OAS1	4.18e-18	2.11e-15	Mixed, incl. 2-5-oligoadenylate synthetase activity, and nephropathia epidemica
NetworkNeighborAL	CL:19402	5	5	9606	OAS2,IFIT1,IFIT3,IFIT2,RSAD2	OAS2,IFIT1,IFIT3,IFIT2,RSAD2	3.92e-12	1.78e-09	Mixed, incl. 4fe-4s single cluster domain, and interferon-induced protein with tetratricopeptide repeats 3
NetworkNeighborAL	CL:19463	4	5	9606	PARP12,DTX3L,PARP14,RNF213	PARP12,DTX3L,PARP14,RNF213	1.2e-09	4.95e-07	Appr-1-p processing enzyme, and DTX3L, RING-HC finger
NetworkNeighborAL	CL:19437	4	13	9606	HERC6,GBP1,IFI44L,ISG15	HERC6,GBP1,IFI44L,ISG15	2.24e-08	8.49e-06	Mixed, incl. isg15-protein conjugation, and interferon-induced protein 44 family
NetworkNeighborAL	CL:19438	3	7	9606	HERC6,GBP1,IFI44L	HERC6,GBP1,IFI44L	6.77e-07	0.00024	Mixed, incl. interferon-induced protein 44 family, and receptor-transporting protein 4
NetworkNeighborAL	CL:19493	2	5	9606	IFIH1,DDX58	IFIH1,DDX58	6.85e-05	0.0222	Caspase recruitment domain, and TRIM25, PRY/SPRY domain
